This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Kenvue's $11.3M ORSL stock frozen in India over misleading ORS labeling

By Freny Patel ( November 13, 2025, 01:14 GMT | Insight) -- An Indian court upheld the Food Safety and Standards Authority of India’s ban on Kenvue’s ORSL drink, citing its misleading similarity to World Health Organization-prescribed clinical formulation used to treat dehydration. The Delhi High Court ruling halts the sale of $11.28 million in stock.American pharmaceutical company Kenvue has suffered a major setback after the Delhi High Court upheld a directive from the Food Safety and Standards Authority of India, or FSSAI, banning the sale of its ORSL Electrolyte Drink. The ruling effectively freezes unsold ORSL stock held by Kenvue’s Indian arm, JNTL Consumer Health, valued at approximately $11.28 million....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections